Cytokinetics Inc
NASDAQ:CYTK

Watchlist Manager
Cytokinetics Inc Logo
Cytokinetics Inc
NASDAQ:CYTK
Watchlist
Price: 34.25 USD 2.67% Market Closed
Market Cap: 4.1B USD

Wall Street
Price Targets

CYTK Price Targets Summary
Cytokinetics Inc

Wall Street analysts forecast CYTK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYTK is 75.71 USD with a low forecast of 41.41 USD and a high forecast of 126 USD.

Lowest
Price Target
41.41 USD
21% Upside
Average
Price Target
75.71 USD
121% Upside
Highest
Price Target
126 USD
268% Upside
Cytokinetics Inc Competitors:
Price Targets
6955
Shandong Boan Biotechnology Co Ltd
26% Downside
LEGN
Legend Biotech Corp
103% Upside
MDGL
Madrigal Pharmaceuticals Inc
40% Upside
VTGN
VistaGen Therapeutics Inc
439% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
43% Upside
CRSP
CRISPR Therapeutics AG
37% Upside
RYTM
Rhythm Pharmaceuticals Inc
3% Downside
IDYA
IDEAYA Biosciences Inc
128% Upside

Revenue
Forecast

Revenue Estimate
Cytokinetics Inc

For the last 8 years the compound annual growth rate for Cytokinetics Inc's revenue is -20%. The projected CAGR for the next 3 years is 184%.

-20%
Past Growth
184%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cytokinetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Cytokinetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYTK's stock price target?
Price Target
75.71 USD

According to Wall Street analysts, the average 1-year price target for CYTK is 75.71 USD with a low forecast of 41.41 USD and a high forecast of 126 USD.

What is Cytokinetics Inc's Revenue forecast?
Projected CAGR
184%

For the last 8 years the compound annual growth rate for Cytokinetics Inc's revenue is -20%. The projected CAGR for the next 3 years is 184%.

Back to Top